Shizuoka, Japan

Kazuyoshi Nishiie

This inventor holds 1 USPTO granted patent. Top assignee: Toyo Jozo Kabushiki Kaisha. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuyoshi Nishiie. Retrieved from https://idiyas.com/inventor/kazuyoshi-nishiie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuyoshi Nishiie: Innovator in Diacyl Penicillins

Introduction

Kazuyoshi Nishiie is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel diacyl penicillins. His work has implications for antibiotic development and medicinal chemistry.

Latest Patents

Nishiie's most recent patent focuses on diacyl penicillins and methods for their production. The patent describes a unique formula for diacyl penicillins, where R can be various organic groups, and outlines the process for synthesizing these compounds. This innovation is crucial for enhancing the efficacy of penicillin derivatives.

Career Highlights

Throughout his career, Kazuyoshi Nishiie has been associated with Toyo Jozo Kabushiki Kaisha, where he has contributed to various research initiatives. His expertise in organic chemistry and pharmacology has positioned him as a key figure in his field. Nishiie holds 1 patent that showcases his innovative approach to drug development.

Collaborations

Nishiie has worked alongside esteemed colleagues such as Jinnosuke Abe and Tetsuo Watanabe. Their collaborative efforts have further advanced the research and development of pharmaceutical compounds.

Conclusion

Kazuyoshi Nishiie's contributions to the field of diacyl penicillins highlight his innovative spirit and dedication to advancing pharmaceutical science. His work continues to influence the development of new antibiotics and therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…